in this issue
Regions :: North America :: U.S.
Ferro sells pharma business
9:23 AM MDT | April 1, 2013 | Robert Westervelt
Ferro has completed the sale of its pharmaceuticals business, Pfanstiehl Laboratories, to private equity firm Med Opportunity Partners (Greenwich, CT). Ferro will receive $16.9 million cash and an incentive payment of up to $8 million, payable over 2 years based on the business’ earnings performance....
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee